SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications - Neurodegenerative

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (348)4/21/2010 1:08:32 AM
From: John McCarthy  Read Replies (1) of 448
 
I am in over my head "language wise" but got curious
as to how many companies are in this IVIG thingie.

Googled :IVIG products

This spit out what I was after -- but suspect it is
a short list as opposed to complete list ...

Product ..................... Manufactured By

Liquids:
---------------
Flebogamma® ..................... Grifols
Privigen ..................... Liquid CSL Behring
Gamunex ..................... Talecris Biotherapeutics-USA
Octagam® ..................... Octapharma
Gammagard ..................... Liquid® Baxter Healthcare

Powders:
---------------
Carimune ..................... NF ZLB Behring
Gammagard® S/D ..................... Baxter Healthcare
Gammar® P ZLB ..................... Behring
Iveegam EN ..................... Baxter Healthcare
Panglobulin® NF .....................American Red Cross
Polygam® S/D .....................American Red Cross

Would you know a goto source link that identifies all
makers (world-wide)

And was curious if liquid vs powder makes a difference.

nbninfusions.com

Various other diseases and immune disorders where IVIG is used include:

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Multiple Sclerosis (MS)
Myasthenia Gravis(MG)
Systenic Lupus Erythematosus (SLE)
Guillain-Barre Syndrome (GBS)
Autoimmune Diabetic Neuropathy
Polymyositis
Multifocal Motor Neuropathy (MMN)
Dermatomyositis
Rheumatoid Arthritis (RA)
Common Variable Immunodeficiency (CVID)
Hypogammaglobulinemia
Severe Combined Immunodeficiency (SCID)
Wiskott-Aldrich Syndrome (WAS)
X-Linked Agammaglobulinemia (XLA)
other connective tissue disorders

EDIT
wendyusuallywanders.wordpress.com

From what I have read, each bottle of Ig contains plasma components from at least 3000 people. I believe I got 8 bottles worth.

That means the immune system components of perhaps 240,000 to 800,000 people are now running around inside of me No wonder a war is raging!

Each batch of IVIg is made by cold ethanol fractionation (the Cohn process) of human plasma derived from pools of 3000 to 10 000 donors.

The product is purified by enzymatic treatment at a low pH, which is followed by fractionation and chromatography.

The purified immunoglobulin is stabilized with

glucose,
maltose,
glycine,
sucrose,
mannitol,
or albumin.

The final product contains more than

95% IgG,
less than 2.5% IgA,
and a negligible amount of IgM.

Among the IgG subclasses,

IgG1 varies from 55% to 70%,
IgG2 from 30% to 38%,
IgG3 from 0% to 6%,
and IgG4 from 0.7% to 2.6%,

according to the size and composition of the donor pools used in the various proprietary IVIg preparations.

EDIT EDIT

IVIG products March 2006

clinimmsoc.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext